Literature DB >> 32795176

Particle therapy in the future of precision therapy.

Lukas Schaub1,2,3, Semi Ben Harrabi1,2,3,4,5, Juergen Debus1,2,3,4,5,6.   

Abstract

The first hospital-based treatment facilities for particle therapy started operation about thirty years ago. Since then, the clinical experience with protons and carbon ions has grown continuously and more than 200,000 patients have been treated to date. The promising clinical results led to a rapidly increasing number of treatment facilities and many new facilities are planned or under construction all over the world. An inverted depth-dose profile combined with potential radiobiological advantages make charged particles a precious tool for the treatment of tumours that are particularly radioresistant or located nearby sensitive structures. A rising number of trials have already confirmed the benefits of particle therapy in selected clinical situations and further improvements in beam delivery, image guidance and treatment planning are expected. This review summarises some physical and biological characteristics of accelerated charged particles and gives some examples of their clinical application. Furthermore, challenges and future perspectives of particle therapy will be discussed.

Entities:  

Mesh:

Year:  2020        PMID: 32795176      PMCID: PMC7548373          DOI: 10.1259/bjr.20200183

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  107 in total

1.  RBE of carbon ions: experimental data and the strategy of RBE calculation for treatment planning.

Authors:  W K Weyrather; G Kraft
Journal:  Radiother Oncol       Date:  2004-12       Impact factor: 6.280

2.  Radiological use of high energy deuterons and alpha particles.

Authors:  C A TOBIAS; H O ANGER; J H LAWRENCE
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1952-01

Review 3.  Proton vs carbon ion beams in the definitive radiation treatment of cancer patients.

Authors:  Herman Suit; Thomas DeLaney; Saveli Goldberg; Harald Paganetti; Ben Clasie; Leo Gerweck; Andrzej Niemierko; Eric Hall; Jacob Flanz; Josh Hallman; Alexei Trofimov
Journal:  Radiother Oncol       Date:  2010-02-23       Impact factor: 6.280

4.  High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results.

Authors:  J Debus; M Wuendrich; A Pirzkall; A Hoess; W Schlegel; I Zuna; R Engenhart-Cabillic; M Wannenmacher
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

5.  Fast neutron treatment for squamous cell carcinoma of the head and neck: final report of Edinburgh randomised trial.

Authors:  R H MacDougall; J A Orr; G R Kerr; W Duncan
Journal:  BMJ       Date:  1990-12-01

6.  Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).

Authors:  Stephanie E Combs; Sebastian Adeberg; Jan-Oliver Dittmar; Thomas Welzel; Stefan Rieken; Daniel Habermehl; Peter E Huber; Jürgen Debus
Journal:  Radiother Oncol       Date:  2012-08-18       Impact factor: 6.280

Review 7.  Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture.

Authors:  C B Wilson
Journal:  J Neurosurg       Date:  1994-11       Impact factor: 5.115

8.  Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study.

Authors:  Anna V Nikoghosyan; Geraldine Rauch; Marc W Münter; Alexandra D Jensen; Stephanie E Combs; Meinhard Kieser; Jürgen Debus
Journal:  BMC Cancer       Date:  2010-11-05       Impact factor: 4.430

9.  A retrospective multicenter study of carbon-ion radiotherapy for major salivary gland carcinomas: Subanalysis of J-CROS 1402 HN.

Authors:  Kazuhiko Hayashi; Masashi Koto; Yusuke Demizu; Jun-Ichi Saitoh; Hiroaki Suefuji; Tomoaki Okimoto; Tatsuya Ohno; Yoshiyuki Shioyama; Ryo Takagi; Hiroaki Ikawa; Kenji Nemoto; Takashi Nakano; Tadashi Kamada
Journal:  Cancer Sci       Date:  2018-04-27       Impact factor: 6.716

10.  Commissioning and initial experience with the first clinical gantry-mounted proton therapy system.

Authors:  Tianyu Zhao; Baozhou Sun; Kevin Grantham; Leith Rankine; Bin Cai; Sreekrishna M Goddu; Lakshmi Santanam; Nels Knutson; Tiezhi Zhang; Michael Reilly; Beth Bottani; Jeffrey Bradley; Sasa Mutic; Eric E Klein
Journal:  J Appl Clin Med Phys       Date:  2016-03-08       Impact factor: 2.102

View more
  7 in total

1.  125 years of BJR and radiological research: reflecting on the anniversary series in celebration of the world's oldest radiology journal.

Authors:  Simon A Jackson; Kevin M Prise
Journal:  Br J Radiol       Date:  2021-01-01       Impact factor: 3.039

2.  Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST).

Authors:  Mimoza M Ristova; Vesna Gershan; Herwig Schopper; Ugo Amaldi; Manjit Dosanjh
Journal:  Adv Radiat Oncol       Date:  2021-08-09

3.  Exploring the translational challenge for medical applications of ionising radiation and corresponding radiation protection research.

Authors:  Sophie Bockhold; Shane J Foley; Louise A Rainford; Riccardo Corridori; Annika Eberstein; Christoph Hoeschen; Mark W Konijnenberg; Susan Molyneux-Hodgson; Graciano Paulo; Joana Santos; Jonathan P McNulty
Journal:  J Transl Med       Date:  2022-03-18       Impact factor: 5.531

4.  Editorial: Medical Application and Radiobiology Research of Particle Radiation.

Authors:  Fei Ye; Chao Sun; Yi Xie; Bing Wang; Lu Cai
Journal:  Front Public Health       Date:  2022-07-22

Review 5.  Future Developments in Charged Particle Therapy: Improving Beam Delivery for Efficiency and Efficacy.

Authors:  Jacinta Yap; Andrea De Franco; Suzie Sheehy
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 5.738

Review 6.  Physical and Biological Characteristics of Particle Therapy for Oncologists.

Authors:  Hwa Kyung Byun; Min Cheol Han; Kyungmi Yang; Jin Sung Kim; Gyu Sang Yoo; Woong Sub Koom; Yong Bae Kim
Journal:  Cancer Res Treat       Date:  2021-06-16       Impact factor: 4.679

Review 7.  Who Will Benefit from Charged-Particle Therapy?

Authors:  Kyung Su Kim; Hong-Gyun Wu
Journal:  Cancer Res Treat       Date:  2021-06-21       Impact factor: 4.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.